BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32830899)

  • 1. Leptomeningeal Enhancement on 3D-FLAIR MRI in Multiple Sclerosis: Systematic Observations in Clinical Practice.
    Titelbaum DS; Engisch R; Schwartz ED; Napoli SQ; Sloane JA; Samaan S; Katz JD; Lathi ES
    J Neuroimaging; 2020 Nov; 30(6):917-929. PubMed ID: 32830899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance.
    Harrison DM; Allette YM; Zeng Y; Cohen A; Dahal S; Choi S; Zhuo J; Hua J
    PLoS One; 2024; 19(5):e0300298. PubMed ID: 38809920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Postcontrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis.
    Zivadinov R; Ramasamy DP; Hagemeier J; Kolb C; Bergsland N; Schweser F; Dwyer MG; Weinstock-Guttman B; Hojnacki D
    AJNR Am J Neuroradiol; 2018 Apr; 39(4):642-647. PubMed ID: 29439125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly Sensitive 3-Tesla Real Inversion Recovery MRI Detects Leptomeningeal Contrast Enhancement in Chronic Active Multiple Sclerosis.
    Okar SV; Dieckhaus H; Beck ES; Gaitán MI; Norato G; Pham DL; Absinta M; Cortese IC; Fletcher A; Jacobson S; Nair G; Reich DS
    Invest Radiol; 2024 Mar; 59(3):243-251. PubMed ID: 37493285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions.
    Zurawski J; Tauhid S; Chu R; Khalid F; Healy BC; Weiner HL; Bakshi R
    Mult Scler; 2020 Feb; 26(2):177-187. PubMed ID: 31714181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No association between cortical lesions and leptomeningeal enhancement on 7-Tesla MRI in multiple sclerosis.
    Ighani M; Jonas S; Izbudak I; Choi S; Lema-Dopico A; Hua J; O'Connor EE; Harrison DM
    Mult Scler; 2020 Feb; 26(2):165-176. PubMed ID: 31573837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases.
    Absinta M; Cortese IC; Vuolo L; Nair G; de Alwis MP; Ohayon J; Meani A; Martinelli V; Scotti R; Falini A; Smith BR; Nath A; Jacobson S; Filippi M; Reich DS
    Neurology; 2017 Apr; 88(15):1439-1444. PubMed ID: 28283598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of MRI leptomeningeal enhancement with disability worsening in progressive multiple sclerosis: A clinical and post-mortem study.
    Vercellino M; Costantini G; Cogoni M; Lequio L; Sciortino P; De Negri F; Marasciulo S; Valentini C; Bosa C; Garelli P; Rolando A; Calvo A; Morana G; Cavalla P
    Mult Scler; 2023 Nov; 29(13):1526-1539. PubMed ID: 37740714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical involvement and leptomeningeal inflammation in myelin oligodendrocyte glycoprotein antibody disease: A three-dimensional fluid-attenuated inversion recovery MRI study.
    Tzanetakos D; Tzartos JS; Vakrakou AG; Breza M; Velonakis G; Stathopoulos P; Pantou E; Markakis I; Papadimitriou D; Karavasilis E; Toulas P; Evangelopoulos ΜE; Koutsis G; Anagnostouli M; Stefanis L; Kilidireas C
    Mult Scler; 2022 Apr; 28(5):718-729. PubMed ID: 34410179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients.
    Friedli C; Wagner F; Hammer HN; Kamber N; Wiest R; Diem L; Chan A; Salmen A; Hoepner R
    Mult Scler; 2023 Jan; 29(1):63-73. PubMed ID: 36113094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Persistence of Meningeal Enhancement on Postcontrast 7T 3D-FLAIR MRI in Multiple Sclerosis.
    Jonas SN; Izbudak I; Frazier AA; Harrison DM
    AJNR Am J Neuroradiol; 2018 Oct; 39(10):1799-1805. PubMed ID: 30213813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningeal contrast enhancement in multiple sclerosis: assessment of field strength, acquisition delay, and clinical relevance.
    Harrison DM; Allette YM; Zeng Y; Cohen A; Dahal S; Choi S; Zhuo J; Hua J
    medRxiv; 2024 Mar; ():. PubMed ID: 38496664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptomeningeal Contrast Enhancement Is Related to Focal Cortical Thinning in Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional MRI Study.
    Bergsland N; Ramasamy D; Tavazzi E; Hojnacki D; Weinstock-Guttman B; Zivadinov R
    AJNR Am J Neuroradiol; 2019 Apr; 40(4):620-625. PubMed ID: 30872420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal cortical atrophy following transient meningeal enhancement in a progressive multiple sclerosis.
    Bonnan M; Money P; Desblache P; Marasescu R; Puvilland LM; Demasles S; Dahan C; Krim E; Tucholka A; Doyle S; Barroso B
    Neurol Sci; 2021 May; 42(5):1959-1961. PubMed ID: 32995987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptomeningeal Enhancement at 7T in Multiple Sclerosis: Frequency, Morphology, and Relationship to Cortical Volume.
    Harrison DM; Wang KY; Fiol J; Naunton K; Royal W; Hua J; Izbudak I
    J Neuroimaging; 2017 Sep; 27(5):461-468. PubMed ID: 28464368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis.
    Hildesheim FE; Ramasamy DP; Bergsland N; Jakimovski D; Dwyer MG; Hojnacki D; Lizarraga AA; Kolb C; Eckert S; Weinstock-Guttman B; Zivadinov R
    Mult Scler Relat Disord; 2021 Jan; 47():102653. PubMed ID: 33333417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis.
    Absinta M; Vuolo L; Rao A; Nair G; Sati P; Cortese IC; Ohayon J; Fenton K; Reyes-Mantilla MI; Maric D; Calabresi PA; Butman JA; Pardo CA; Reich DS
    Neurology; 2015 Jul; 85(1):18-28. PubMed ID: 25888557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study.
    Zivadinov R; Ramasamy DP; Vaneckova M; Gandhi S; Chandra A; Hagemeier J; Bergsland N; Polak P; Benedict RH; Hojnacki D; Weinstock-Guttman B
    Mult Scler; 2017 Sep; 23(10):1336-1345. PubMed ID: 27811339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot trial of ocrelizumab for modulation of meningeal enhancement in multiple sclerosis.
    Dahal S; Allette YM; Naunton K; Harrison DM
    Mult Scler Relat Disord; 2024 Jan; 81():105344. PubMed ID: 38035495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susac's syndrome: Leptomeningeal enhancement on 3D FLAIR MRI.
    Engisch R; Titelbaum DS; Chilver-Stainer L; Kellner-Weldon F
    Mult Scler; 2016 Jun; 22(7):972-4. PubMed ID: 27207452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.